Guided Therapeutics (GTHP) Price & Analysis

30 Followers

GTHP Stock Chart & Stats

$0.20

>-$0.01(-1.55%)

At close: Jan 08 4:00 PM EST

$0.20

>-$0.01(-1.55%)

Day’s Range― - ―

52-Week Range$0.12 - $0.54

Previous CloseN/A

Volume813.00

Average Volume (3M)12.33K

Market Cap

$25.10M

Enterprise Value$24.66M

Total Cash (Recent Filing)$369.00K

Total Debt (Recent Filing)$2.79M

Price to Earnings (P/E)―

Beta2.04

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares Outstanding96,537,346

10 Day Avg. Volume11,951

30 Day Avg. Volume12,334

Financial Highlights & Ratios

PEG Ratio2.29

Price to Book (P/B)-7.05

Price to Sales (P/S)55.21

P/FCF Ratio-39.57

Enterprise Value/Market Cap0.98

Enterprise Value/Revenue32.15

Enterprise Value/Gross Profit47.33

Enterprise Value/Ebitda-9.09

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Guided Therapeutics News

Guided receives $80,000 payment as fourth installment of purchase order

Guided Therapeutics (GTHP) announced that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical...

5d ago

GTHP

Guided Therapeutics enters new agreement with Yuanshuo Medical Instruments

Guided Therapeutics (GTHP) reached a new agreement with Yuanshuo Medical Instruments Corporation to supply them with LuViva instruments,...

13d ago

GTHP

Guided Therapeutics files PMA application clinical report with FDA

Guided Therapeutics (GTHP) filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration....

1M ago

GTHP

Guided Therapeutics says preliminary analysis of FDA study data completed

Guided Therapeutics (GTHP) provided several updates in conjunction with the Company’s 2025 10k financial report, filed on March...

4M ago

GTHP

Guided Therapeutics Completes Warrant Exchange to Boost Liquidity

An update from Guided Therapeutics ( ($GTHP) ) is now available. On March 2, 2026, Guided Therapeutics, Inc....

5M ago

GTHP

Guided Therapeutics provides update on U.S. trial for LuViva cervical scan

Guided Therapeutics (GTHP) announced it had enrolled enough patients, approximately 430, to begin closing out its U.S. FDA...

12M ago

GTHP

Guided Therapeutics: Data from NMPA clinical study signed off on by all sites

Guided Therapeutics announced that physicians from four prestigious medical centers have completed their review and signed off on...

2y ago

GTHP

Guided Therapeutics reports completion of study for Chinese regulatory approval

Guided Therapeutics announced the completion of the clinical trial for marketing and sales approval of the Company’s LuViva...

3y ago

GTHP

GTHP FAQ

What was Guided Therapeutics Inc’s price range in the past 12 months?

Guided Therapeutics Inc lowest stock price was $0.12 and its highest was $0.54 in the past 12 months.

What is Guided Therapeutics Inc’s market cap?

Guided Therapeutics Inc’s market cap is $25.10M.

When is Guided Therapeutics Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Guided Therapeutics Inc’s earnings last quarter?

Currently, no data Available

Is Guided Therapeutics Inc overvalued?

According to Wall Street analysts Guided Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Guided Therapeutics Inc pay dividends?

Guided Therapeutics Inc does not currently pay dividends.

What is Guided Therapeutics Inc’s EPS estimate?

Guided Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Guided Therapeutics Inc have?

Guided Therapeutics Inc has 96,537,346 shares outstanding.

What happened to Guided Therapeutics Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Guided Therapeutics Inc?

Currently, no hedge funds are holding shares in GTHP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Guided Therapeutics Inc

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.